Queens University, Kingston
Reports add new data to breast cancer research
Published in Biotech Law Weekly, November 18th, 2005
Study 1: The effect of chemotherapy-induced amenorrhea during adjuvant therapy was studied recently by scientists in Canada.
Scientists sought "To investigate the therapeutic impact of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer" by conducting "a retrospective cohort study of a National Cancer Institute of Canada Clinical Trials Group phase III trial involving premenopausal patients randomized to receive cyclophosphamide, methotrexate, and fluorouracil (CMF), versus intensive cyclophosphamide, epirubicin, and fluorouracil (CEF)."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2005-11-18)
More Articles from Biotech Law Weekly
- Boston Medical Center
Growth hormone is illegal for off-label anti-aging use - Dartmouth Medical School
Health cost disparity is partly due to physician behavior - EduNeering
Knowledge solutions company rolls out Medicare Part D nine-course curriculum - EntreMed, Inc.
Patents for rheumatoid arthritis compound granted by European Patent Office - IMS Health
Global pharmaceutical market set to grow 6-7% in 2006; U.S. demand increasing - Intranasal Therapeutics, Inc.
Patent request filed for THC nasal spray to control nausea and vomiting - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
